QuickView for SNCB;jsessionid=9E4BF03F1477996B788AD77093E11300 (gene)

1. Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer's Disease.
2. Counter-regulation of alpha- and beta-synuclein expression at the transcriptional level.
3. β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-…
4. New brain-specific beta-synuclein isoforms show expression ratio changes in Lewy body diseases.
5. Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggrega…

There were no clinical trials for SNCB;jsessionid=9E4BF03F1477996B788AD77093E11300